MWA
Moser Wealth Advisors’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.86K | Sell |
100
-250
| -71% | -$12.2K | ﹤0.01% | 163 |
|
|
2025
Q1 | $11.9K | Hold |
350
| – | – | 0.01% | 125 |
|
|
2024
Q4 | $13.8K | Hold |
350
| – | – | 0.01% | 110 |
|
|
2024
Q3 | $16.4K | Buy |
350
+50
| +17% | +$2.35K | 0.01% | 110 |
|
|
2024
Q2 | $16.2K | Buy |
300
+100
| +50% | +$5.4K | 0.01% | 112 |
|
|
2024
Q1 | $13.6K | Hold |
200
| – | – | 0.01% | 115 |
|
|
2023
Q4 | $12.5K | Hold |
200
| – | – | 0.01% | 112 |
|
|
2023
Q3 | $9.08K | Hold |
200
| – | – | 0.01% | 110 |
|
|
2023
Q2 | $11.2K | Buy |
+200
| New | +$11.2K | 0.01% | 107 |
|
|
2022
Q4 | $8.13K | Buy |
200
+150
| +300% | +$6.1K | 0.01% | 105 |
|
|
2022
Q3 | $3K | Hold |
50
| – | – | ﹤0.01% | 126 |
|
|
2022
Q2 | $3K | Hold |
50
| – | – | ﹤0.01% | 122 |
|
|
2022
Q1 | $3K | Hold |
50
| – | – | ﹤0.01% | 125 |
|
|
2021
Q4 | $4K | Hold |
50
| – | – | ﹤0.01% | 128 |
|
|
2021
Q3 | $6K | Buy |
+50
| New | +$6K | ﹤0.01% | 122 |
|